Israel’s Teva has joined with Iceland’s Alvotech to commercialize five biosimilar product candidates in the US. Biosimilars are slightly different versions of already approved treatments. They are not the same as “generics” but require less testing than the original and are much cheaper.

https://www.timesofisrael.com/teva-joins-forces-with-icelandic-firm-to-gain-edge-on-biosimilars/